Follow us on Twitter
twitter icon@FreshPatents


Weight Management patents

      

This page is updated frequently with new Weight Management-related patent applications.




 Weight management system and method patent thumbnailWeight management system and method
Aspects of the present disclosure relate to data analysis, and in particular, to the monitoring, management, and/or analysis of heath data and/or body weight data obtained from weighing scales and/or body sensors.. .
Scale Down


 Non-hygroscopic salts of 5-ht2c agonists patent thumbnailNon-hygroscopic salts of 5-ht2c agonists
Salts of the 5-ht2c-receptor agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine, and dosage forms comprising them that are useful for, inter alia, weight management.. .
Arena Pharmaceuticals, Inc.


 Method and system for improving weight management interventions by assessing variability in serial weight measurements patent thumbnailMethod and system for improving weight management interventions by assessing variability in serial weight measurements
The present disclosure features novel methods and systems of using a computer system to facilitate improvement of a weight management intervention. In one embodiment, a method of improving a weight management intervention comprises receiving, by an analysis agent executing on a processor, a daily weight measurement of a patient enrolled in the weight management intervention.

 Novel compounds as diacylglycerol acyltransferase inhibitors patent thumbnailNovel compounds as diacylglycerol acyltransferase inhibitors
This invention relates to novel compounds which are inhibitors of acyl coenzyme a: diacylglycerol acyltransferase 1 (dgat-1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination with weight management therapies or other triglyceride lowering therapy for the prevention or treatment of diseases related to dgat-1 dysfunction or where modulation of dgat-1 activity may have therapeutic benefit including but not limited to obesity, obesity related disorders, genetic (type 1, type 5 hyperlipidemia) and acquired forms of hypertriglyceridemia or hyperlipoproteinemia-related disorders, caused by but not limited to lipodystrophy, hypothyroidism, medications (beta blockers, thiazides, estrogen, glucocorticoids, transplant) and other factors (pregnancy, alcohol intake), hyperlipoproteinemia, chylomicronemia, dyslipidemia, non-alcoholic steatohepatitis, diabetes, insulin resistance, metabolic syndrome, cardiovascular outcomes, angina, excess hair growth (including syndromes associated with hirsutism), nephrotic syndrome, fibrosis such as myocardial, renal and liver fibrosis, hepatitis c virus infection and acne or other skin disorders.. .
Glaxosmithkline Llc


 Randomized weight modulation patent thumbnailRandomized weight modulation
A method of modulating an individual's weight generates a randomized daily caloric intake value based on an individual's body composition and metabolic rates and the individual's specific weight management goals, including weight loss, weight gain, or weight control and eliminates the individual's foreknowledge of future daily caloric or nutritional intake goals. Once the individual's base metabolic rate is determined, a series of categories, each having a different daily caloric intake value, is calculated to provide a range of daily caloric intake values.

 Functional food formula analysis system for personalized body weight management patent thumbnailFunctional food formula analysis system for personalized body weight management
A functional food formula analysis system for personalized body weight management includes a user input unit, a body constitution analysis data unit, a functional food data unit, an analysis server unit, and an analysis result storage unit. The analysis server unit is connected to the other units and is configured for retrieving personal data, personal genetic data, and obesity-associated body constitution data and performing data comparison, exchange, and integration on those data in order to output a personalized functional food formula report to be stored in the analysis result storage unit.
Union Applied Gene Inc.


 Dietary compositions for reducing blood glucose levels and for weight management patent thumbnailDietary compositions for reducing blood glucose levels and for weight management
The present invention provides dietary compositions comprising mulberry extract, coffee extract, bean extract, optionally, dietary fibers, and a nutraceutically acceptable carrier. The present invention further provides methods for preventing the increase in postprandial hyperglycemia and hypoglycemia, hyperinsulinemia and diseases and disorders associated therewith, including, endothelial dysfunction, inflammatory conditions, oxidative stress, hyperlipidemia, and consecutive pathologies like insulin resistance, diabetes, visceral obesity, hypertension and cardiovascular diseases..
Marmar Investment Sp. Z O.o.


 Absorbent ingestible agents and associated methods of manufacture and use patent thumbnailAbsorbent ingestible agents and associated methods of manufacture and use
Appetite suppression and weight management achieved through pre-meal ingestion of temporary gastric bulking agents in the form of superabsorbent polymer hydrogels (saphs) selected from among a group consisting of crosslinked polycarboxylic acid moieties is described. The preferred compositions and manufacturing methods of ultrapure preparations of ingestible forms; as well as the preferred methods of use, dosage and administration; distribution and delivery of saph materials are also described..
Wellosophy Corporation


 Safflower oil emulsion as dietary supplement and preparation thereof patent thumbnailSafflower oil emulsion as dietary supplement and preparation thereof
Novel safflower oil emulsion and method of preparation. The safflower oil is 100% all natural, non-genetically modified organism (gmo), expeller pressed, solvent free, linoleic fatty acid rich oil wherein the linoleic fatty acid content is in a range from approximately 70% to approximately 80% of the total safflower oil that is mixed with a purified water and a mixture of at least one of an emulsifier, a flavoring, a natural sweetener, a natural coloring agent, and a gum.
Innovitamin Organics, Llc


 Methods and compositions for using cinnamaldehyde and zinc for weight management patent thumbnailMethods and compositions for using cinnamaldehyde and zinc for weight management
Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde and zinc but otherwise identical.
Nestec S.a.


Systems and methods of using magnets for weight management

A method of managing weight includes performing a body type test on a patient for identifying at least one location for treatment, and placing a magnetic device over the at least one location for influencing energy flow in the patient. The magnetic device includes a set of four magnetic discs arranged in an array including two having negative magnetic poles lying in a first plane and two having positive magnetic poles lying in the first plane.
Blmj Holdings, Llc

Implement weight management systems, methods, and apparatus

Systems, methods and apparatus are provided for managing implement weight. In some embodiments, a position sensor is used to determine a position of the wing section and a downforce applied to the wing is modified in order to lower the wing section.
Precision Planting Llc

Shunting of dietary lipids including cholesterol

Methods and devices for redirecting at least a portion of a fluid from the mesenteric lymphatic system for elimination from the body are disclosed. The fluid may be redirected for elimination through the urinary system or redirected outside the body.
Boston Scientific Scimed, Inc.

Method and weight management utilizing an intra-oral device

An intra-oral device for weight management includes a carrier having a resiliently deformable protuberance on its outer surface. The protuberance may comprise a bite-pad having a height that varies along its length, with the apex being aligned with a first molar of a dental arch of the user.
Dynamic Mouth Devices, L.l.c.

Methods and compositions for increasing energy expenditure using cinnamaldehyde

Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde but otherwise identical.
Nestec S.a.

Formulations for beneficially altering the microbiome

Several embodiments of the invention provide a unique system of formulations adapted to beneficially alter the microbiome. In one embodiment, the invention comprises four oral formulations designed to work synergistically to assist in weight management.
Vitamedica Corporation

Meal intended for human consumption

This invention relates to a plurality of compositions for dietary health management and its use in the prevention or treatment of cardiovascular disease or type 2 diabetes, and also in the prevention and/or management of obesity and generally in weight management and loss. Thus a meal intended for human consumption is provided, the meal comprising: (a) 250-650 kilocalories (1045-4180 kilojoules); (b) 10-50, preferably 20-50, more preferably 30-50 g fibre; (c) 10-50, preferably 10-30, more preferably 10-20 g protein; (d) 0 to 5, preferably less than 3 g starch; and (e) 0 to 2, preferably 0 to 1, most preferably 0 to 0.5 g lactose; (f) at least 20, preferably at least 30, most preferably at least 40 mg of any one flavonoid aglycone; and (g) at least 30, preferably at least 40, most preferably at least 50 mg of any one flavonoid glucoside; wherein the meal comprises 75-1000 mg of total flavonoid aglycone and flavonoid glucoside, wherein the meal comprises no more than 250 mg of any one flavonoid aglycone, wherein the meal comprises no more than 250 mg of any one flavonoid glucoside..
Conopco, Inc., D/b/a Unilever

Ketone measurement system capable of detecting and notifying a user of proper insertion of detachable components

Systems and related methods are provided for measuring a ketone in the fluid of a patient or other user. The systems include a portable measurement device for analyzing a plurality of fluid samples and for generating a corresponding plurality of ketone measurement results.
Invoy Technologies, Llc

Composition

The present invention relates to compositions for weight management comprising: a) a microbiome modifying component; b) a satiety modifying component; and c) a metabolic modifying component. The composition may also be used for the treatment of obesity, elevated cholesterol, diabetes, hypertension or heart disease..
Optibiotix Limited

Metabolic analyzer for optimizing health and weight management

A system including a metabolic rate monitor can monitor one or more metabolic determinants to determine a user's metabolic rate. An interval identifier can detect a plurality of intervals corresponding to a least one type of user activity over a time period, wherein each of the plurality of intervals is employed to record the user's metabolic rate determined by the metabolic rate monitor.
Case Western Reserve University

Functional-gel compositions and methods

The present invention relates to functional-gel compositions as medicaments, foods, food ingredients, food supplements and to uses and methods. The functional-gels comprise an edible gelling agent and additionally a dietary protein or a dietary fiber or a combination of both.

Implantable tastemaker with multiple reservoirs and/or substances for automatic taste modification

This invention is a device and method for automatic and selective modification of the taste and/or smell of one or more selected nutrient or food types as food is being digested within a person's mouth. This invention can comprise: multiple taste and/or smell modifying substances; multiple reservoirs for these substances that are implanted within the person's body; and a flow control mechanism that automatically and selectively increases flowable communication between these substances and the person's oral cavity or nasal cavity when a selected nutrient or food is being digested within the person's mouth.
Medibotics Llc

Weight management method

This invention is directed to a weight management method, designed to stabilize and optimize insulin levels.. .

Fiber-optic weight management mat

A weight management mat for passively and automatically monitoring weight for one or more individuals in a household. The weight management mat generally includes a housing having an upper mat and a lower mat between which is sealed a pair of perpendicular sensor arrays.

Enteric-coated functional food ingredients and methods for making the enteric-coated functional food ingredients

Functional food ingredients for delivery to the gastrointestinal tract are delivered. Food products, nutraceuticals, and pharmaceuticals comprising the functional food ingredients, as well as methods for making the functional food ingredients, are also provided.
Intercontinental Great Brands Llc

Salts of lorcaserin with optically active acids

Salts of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine with optically active acids, and pharmaceutical compositions comprising them that are useful for, inter alia, weight management.. .
Arena Pharmaceuticals, Inc.

Incrementally-sized standard-sized eating-ware system for weight management

An incrementally-sized standard-sized eating-ware system and process comprise a plurality of formulas to establish and assign standard sizes to eating-ware. The standard sizes are based on a series of incrementally-sized flat surfaces, and the flat surfaces establish the basis for total volumetric capacity equivalents.
Foqus, Inc.

Petroselinic acid or a combination of active ingredients comprising at least petroselinic acid for promoting weight loss and/or weight maintenance

The present invention relates to the field of weight management and obesity. It concerns petroselinic acid or a combination of active ingredients including at least petroselinic acid and at least one compound chosen from zinc, taurine, one of the salts of same, lycopene and the mixtures thereof, and preferably at least taurine or zinc gluconate and, more preferably still, at least taurine and zinc gluconate, as a drug for oral administration or as a functional food intended to promote weight loss and/or weight maintenance in a human being and/or animal, or indeed intended to fight obesity..

Method use of polymethoxyflavones (pmfs) in body composition management

Synergistic composition of citrus sp. Polymethoxyflavones (pmfs) with catechins of tea sp.

Novel compounds as diacylglycerol acyltransferase inhibitors

This invention relates to novel compounds which are inhibitors of acyl coenzyme a: diacylglycerol acyltransferase 1 (dgat-1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination with weight management therapies or other triglyceride lowering therapy for the prevention or treatment of diseases related to dgat-1 dysfunction or where modulation of dgat-1 activity may have therapeutic benefit including but not limited to obesity, obesity related disorders, genetic (type 1, type 5 hyperlipidemia) and acquired forms of hypertriglyceridemia or hyperlipoproteinemia-related disorders, caused by but not limited to lipodystrophy, hypothyroidism, medications (beta blockers, thiazides, estrogen, glucocorticoids, transplant) and other factors (pregnancy, alcohol intake), hyperlipoproteinemia, chylomicronemia, dyslipidemia, non-alcoholic steatohepatitis, diabetes, insulin resistance, metabolic syndrome, cardiovascular outcomes, angina, excess hair growth (including syndromes associated with hirsutism), nephrotic syndrome, fibrosis such as mycocardial, renal and liver fibrosis, hepatitis c virus infection and acne or other skin disorders.. .
Glaxosmithkline Llc

Food product

A bulk food product, for use in a weight management program, which includes a number of portions each of which comprises a complete meal which includes fiber and essential nutrients from protein, carbohydrate and fat, in proportions to stabilize insulin levels.. .

Eyewear system for monitoring and modifying nutritional intake

This invention is an eyewear-based system and device for monitoring and modifying a person's nutritional intake. This invention can comprise eyewear with an imaging member which automatically records images of food when the person consumes food.

Personal weight management method

An electronic device and method for personal weight management are disclosed, in which a time measuring device is used to measure abstinence periods between consecutive times that a person consumes food and/or beverages containing chemical energy and these intervals are incorporated into the weight management. In order to enable a method that is as simple as possible, but is nevertheless effective and individually tailored to the person, it is proposed that a time value, which depends on the lipid metabolism—in particular on the lipolysis—that is present during the abstinence period, be subtracted from the respective measured abstinence periods and that the results calculated from this be incorporated into the weight management..

System for monitoring and presenting health, wellness and fitness trend data having user selectable parameters

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.
Bodymedia, Inc.

Novel compounds as diacylglycerol acyltransferase inhibitors

This invention relates to novel compounds which are inhibitors of acyl coenzyme a: diacylglycerol acyltransferase 1 (dgat-1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination with weight management therapies or other triglyceride lowering therapy for the prevention or treatment of diseases related to dgat-1 dysfunction or where modulation of dgat-1 activity may have therapeutic benefit including but not limited to obesity, obesity related disorders, genetic (type 1, type 5 hyperlipidemia) and acquired forms of hypertriglyceridemia or hyperlipoproteinemia-related disorders, caused by but not limited to lipodystrophy, hypothyroidism, medications (beta blockers, thiazides, estrogen, glucocorticoids, transplant) and other factors (pregnancy, alcohol intake), hyperlipoproteinemia, chylomicronemia, dyslipidemia, non-alcoholic steatohepatitis, diabetes, insulin resistance, metabolic syndrome, cardiovascular outcomes, angina, excess hair growth (including syndromes associated with hirsutism), nephrotic syndrome, fibrosis such as myocardial, renal and liver fibrosis, hepatitis c virus infection and acne or other skin disorders.. .
Glaxosmithkline Llc

Fat loss composition

Disclosed is a fat loss composition comprising a) a prostaglandin f2alpha analogue, such as cloprostenol, or a pharmaceutically acceptable ester or salt thereof; and b) amino acids 176-191 of human growth hormone. Use of the composition in weight loss, weight management and/or slimming is described..

Novel compounds as diacylglycerol acyltransferase inhibitors

This invention relates to novel compounds which are inhibitors of acyl coenzyme a: diacylglycerol acyltransferase 1 (dgat-1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination with weight management therapies or other triglyceride lowering therapy for the prevention or treatment of diseases related to dgat-1 dysfunction or where modulation of dgat-1 activity may have therapeutic benefit including but not limited to obesity, obesity related disorders, genetic (type 1, type 5 hyperlipidemia) and acquired forms of hypertriglyceridemia or hyperlipoproteinemia-related disorders, caused by but not limited to lipodystrophy, hypothyroidism, medications (beta blockers, thiazides, estrogen, glucocorticoids, transplant) and other factors (pregnancy, alcohol intake), hyperlipoproteinemia, chylomicronemia, dyslipidemia, non-alcoholic steatohepatitis, diabetes, insulin resistance, metabolic syndrome, cardiovascular outcomes, angina, excess hair growth (including syndromes associated with hirsutism), nephrotic syndrome, fibrosis such as mycocardial, renal and liver fibrosis, hepatitis c virus infection and acne or other skin disorders.. .
Glaxosmithkline Llc

Method of weight management

Provided are methods of determining if an individual is a responder to treatment with (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine or a pharmaceutically acceptable salt, solvate or hydrate thereof. Also provided are methods for selecting an individual for treatment with (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine or a pharmaceutically acceptable salt, solvate or hydrate thereof from a plurality of individuals in need of weight management.
Arena Pharmaceuticals, Inc.

System for monitoring and presenting health, wellness, nutrition and fitness data with feedback and coaching engine

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

System for monitoring and presenting health, wellness and fitness data with feedback and coaching engine and activity and pattern detection

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

System for monitoring and presenting health, wellness and fitness data with feedback and coaching engine and activity and pattern detection

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

System for monitoring and presenting health, wellness and fitness data with feedback and coaching engine and activity detection

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

System for monitoring and presenting health, wellness and fitness trend data having user selectable parameters with modeling capability

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

System for monitoring and presenting health, wellness and fitness data with feedback and coaching engine and modeling capability

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

System for monitoring and presenting health, wellness and fitness data with feedback and coaching engine utilizing multiple user data

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

System for monitoring and presenting health, wellness and fitness data with feedback and coaching engine

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

System for monitoring and presenting health, wellness, nutrition and fitness data with feedback and coaching engine and activity detection

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

System for monitoring and presenting health, wellness and fitness data with activity pattern detection and feedback and coaching engine

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

System for monitoring and presenting health, wellness and fitness trend data with activity detection and feedback and coaching engine

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.

System for monitoring and presenting health, wellness and fitness trend data with activity and pattern detection

A nutrition and activity management system is disclosed that monitors energy expenditure of an individual through the use of a body-mounted sensing apparatus. The apparatus is particularly adapted for continuous wear.



Weight Management topics:
  • Weight Management
  • Body Weight
  • Weight Loss
  • Physiologic
  • Tracking System
  • Physiological Conditions
  • Small Intestine
  • Probiotics
  • Lactobacillus
  • Mathematica
  • Mobile Computing
  • Metabolism
  • Physical Activity
  • Disseminate
  • Feedback Control


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Weight Management for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Weight Management with additional patents listed. Browse our RSS directory or Search for other possible listings.


    0.5072

    file did exist - file did put2753

    6 - 1 - 52